Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CMTS0929 for Inflammatory Bowel Disease: a Prospective, Open-label, Single-arm Clinical Study

NCT06844708 is registered in ClinicalTrials.gov with The Second Hospital of Nanjing Medical University as lead sponsor.

NCT NCT06844708
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06844708 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CMTS0929 for Inflammatory Bowel Disease: a Prospective, Open-label, Single-arm Clinical Study
Lead sponsor
The Second Hospital of Nanjing Medical University
Phase
Phase 1
Overall status
Not yet recruiting
Start date
February 20, 2025
Completion date
July 1, 2030
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

inflammatory bowel disease (ibd)